Inhibition by Artocarpus tonkinensis of the development of collagen-induced arthritis in rats

Scandinavian Journal of Immunology

Volumn 61, Issue 3, 2005, Pages 234-241

  Ngoc, D D T ^a,b   Catrina, A I ^a   Lundberg, K ^a   Harris, H E ^a   Ha, N T ^b   Anh, P T ^b   Larsson, Per ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b HANOI MEDICAL UNIVERSITY   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID ETHYL ESTER; COLLAGEN TYPE 2; FREUND ADJUVANT; PROPIDIUM IODIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTHRITIS; ARTICLE; BREADFRUIT; CONTROLLED STUDY; DRUG INDUCED DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNIZATION; LYMPHOCYTE ACTIVATION; NONHUMAN; PLANT LEAF; PLANT ROOT; PRIORITY JOURNAL; RAT; RISK BENEFIT ANALYSIS; T LYMPHOCYTE ACTIVATION; TRADITIONAL MEDICINE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; ARTHRITIS, EXPERIMENTAL; ARTOCARPUS; AUTOIMMUNITY; FEMALE; LYMPHOCYTES; MALE; MEDICINE, ORIENTAL TRADITIONAL; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, INBRED STRAINS; VIETNAM;

EID: 16244389653     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2005.01560.x     Document Type: Article

References (40)

1. Loi DT. Nhung cay thuoc va vi thuoc Vietnam (Glossary of Vietnamese Medicine Plans and Drugs). Hanoi: Hanoi Publishing House for Science and Technics, 1991.
2. Khang NQ, Strosberg AD, Hoebeke J. Purification and characterization of Artocarpus tonkinensis lectin. Biol Biochem Clin Biochem 1988;6:341.
3. Lien TP. Constitutients of Artocapus tokinewis. Pharmazie 1998;5:353.
4. Hien TLKP, Trung TH. Presence of Kaempferol in the leave of Artocarpus tonkinensis. Med Pharm Inf 2002;6:19-21.
5. Dzung NDHT, Ngoc PH, Trung TH. Presence of Ampelopsis in the leave of Artocarpus tonkinensis. Revue Pharmaceutique (Vietnamese) 2002;7:137-40.
6. Ha NTV, Phi PTP et al. Analysis of pathological changes in spleen, thymus and bone-marrow of mice treated by products of traditional medicine (DY1-Artocapus tonkinensis extract). Revue Pharmaceutique (Vietnamese) 1994;2:55-7.
7. Ha NTV, Phi PTP et al. Effects of Artocarpus extract on immunological factors in mice. PhD Thesis (Vietnamese). 1996;88-99.
8. Zhou JR, Yu L, Mai Z et al. Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice. Int J Cancer 2004;108:8-14.
9. Cerqueira F, Cordeiro-da-Silva A, Araujo N et al. Inhibition of lymphocyte proliferation by prenylated flavones: artelastin as a potent inhibitor. Life Sci 2003;73:2321-34.
10. Billard C, Izard JC, Roman V et al. Comparative antiproliferative and apoptotic effects of resveratrol, epsilon-viniferin and vine-shots derived polyphenols (vineatrols) on chronic B lymphocytic leukaemia cells and normal human lymphocytes. Leuk Lymphoma 2002;43:1991-2002.
11. Barnes S, Boersma B, Patel R et al. Isoflavonoids and chronic disease: mechanisms of action. Biofactors 2000;12:209-15.
12. Harris EDJ. Text book of Rheumatology. Philadelphia: Saunders, 1996.
13. Zwerina J, Hayer S, Tohidast-Akrad M et al. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction. Arthritis Rheum 2004;50:277-90.
14. Kobelt G, Eberhardt K, Geborek P. TNF inhibitors in the treatment of rheumatoid arthritis in clinical practice: costs and outcomes in a follow up study of patients with RA treated with etanercept or infliximab in southern Sweden. Ann Rheum Dis 2004;63:4-10.
15. Stone MA, Payne U, Pacheco-Tena C et al. Cytokine correlates of clinical response patterns to infliximab treatment of ankylosing spondylitis. Ann Rheum Dis 2004;63:84-7.
16. Holmdahl R, Andetsson M, Goldschmidt TJ et al. Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol Rev 1990;118:193-232.
17. Klareskog L, Olsson T. Autoimmunity to collagen II and myelin basic protein: comparative studies in humans and rodents. Immunol Rev 1990;118:285-310.
18. Kato F, Nomura M, Nakamura K. Arthritis in mice induced by a single immunisation with collagen. Ann Rheum Dis 1996;55:535-9.
19. Andersson M, Holmdahl R. Analysis of type II collagen-reactive T cells in the mouse. I. Different regulation of autoreactive vs. non-autoreactive anti-type II collagen T cells in the DBA/1 mouse. Eur J Immunol 1990;20:1061-6.
20. Smith BD, Martin GR, Miller EJ et al. Nature of the collagen synthesized by a transplanted chondrosarcoma. Arch Biochem Biophys 1975;166:181-6.
21. Larsson P, Kleinau S, Holmdahl R et al. Homologous type II collagen-induced arthritis in rats. Characterization of the disease and demonstration of clinically distinct forms of arthritis in two strains of rats after immunization with the same collagen preparation. Arthritis Rheum 1990;33:693-701.
22. Larsson P, Mattsson L, Klareskog L et al. A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia. Clin Exp Immunol 1998;114:277-83.
23. Kerlund K, Erlandsson Harris H, Tracey KJ et al. Anti-inflammatory effects of a new tumour necrosis factor-alpha (TNF-alpha) inhibitor (CNI-1493) in collagen-induced arthritis (CIA) in rats. Clin Exp Immunol 1999;115:32-41.
24. Kleinau S, Erlandsson H, Holmdahl R et al. Adjuvant oils induce arthritis in the DA rat. I. Characterization of the disease and evidence for an immunological involvement. J Autoimmun 1991;4:871-80.
25. Mattsson L, Lorentzen JC, Svelander L et al. Immunization with alum-collagen II complex suppresses the development of collagen-induced arthritis in rats by deviating the immune response. Scand J Immunol 1997;46:619-24.
26. Vermes I, Haanen C, Steffens-Nakken H et al. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995;184:39-51.
27. Catrina SB, Catrina AI, Sirzen F et al. A cytotoxic, apoptotic, low-molecular weight factor from pineal gland. Life Sci 1999;65:1047-57.
28. Catrina AI, Ulfgren AK, Lindblad S et al. Low levels of apoptosis and high FLIP expression in early rheumatoid arthritis synovium. Ann Rheum Dis 2002;61:934-6.
29. Catchpole B, Staines NA, Hamblin AS. Antigen presentation of Type II collagen in rats. Clin Exp Immunol 2001;125:478-84.
30. Svensson L, Jirholt J, Holmdahl R et al. B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin Exp Immunol 1998;111:521-6.
31. Nakamura A, Nukiwa T, Takai T. Deregulation of peripheral B-cell development in enhanced severity of collagen-induced arthritis in FcgammaRIIB-deficient mice. J Autoimmun 2003;20:227-36.
32. Klareskog LRH, Larsson E, Wegzell H. Role of the T lymphocytes in collagen II induced arthritis in rat. Clin Exp Immunol 1983;51:117-25.
33. Brand DD, Kang AH, Rosloniec EF. Immunopathogenesis of collagen arthritis. Springer Semin Immunopathol 2003;25:3-18.
34. Goldschmidt TJ, Holmdahl R. Anti-T cell receptor antibody treatment of rats with established autologous collagen-induced arthritis: suppression of arthritis without reduction of anti-type II collagen autoantibody levels. Eur J Immunol 1991;21:1327-30.
35. Goldschmidt TJ, Holmdahl R. Therapeutic effects of monoclonal antibodies to [alpha] [beta]TCR but not to CD4 on collagen-induced arthritis in the rat. Cell Immunol 1994;154:240-8.
36. Pope RM. Apoptosis as a therapeutic tool in rheumatoid arthritis. Nat Rev Immunol 2002;2:527-35.
37. Rabinovich GA, Riera CM, Sotomayor CE. Galectin-1, an alternative signal for T cell death, is increased in activated macrophages. Braz J Med Biol Res 1999;32:557-67.
38. Judge TA, Desai NM, Yang Z et al. Utility of adenoviral-mediated Fas ligand gene transfer to modulate islet allograft survival. Transplantation 1998;66:426-34.
39. Cutolo M. Etanercept improves rheumatoid arthritis partially responsive to methotrexate. Clin Exp Rheumatol 2001;19:626-7.
40. Rodenburg RJ, Ganga A, van Lent PL et al. The antiinflammatory drug sujfasalazine inhibits tumor necrosis factor alpha expression in macrophages by inducing apoptosis. Arthritis Rheum 2000;43:1941-50.